These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 22251555

  • 1. Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide.
    Tang D, Hight MR, McKinley ET, Fu A, Buck JR, Smith RA, Tantawy MN, Peterson TE, Colvin DC, Ansari MS, Nickels M, Manning HC.
    J Nucl Med; 2012 Feb; 53(2):287-94. PubMed ID: 22251555
    [Abstract] [Full Text] [Related]

  • 2. Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline.
    Buck JR, McKinley ET, Hight MR, Fu A, Tang D, Smith RA, Tantawy MN, Peterson TE, Colvin D, Ansari MS, Baldwin RM, Zhao P, Guleryuz S, Manning HC.
    J Nucl Med; 2011 Jan; 52(1):107-14. PubMed ID: 21149488
    [Abstract] [Full Text] [Related]

  • 3. The translocator protein radioligand 18F-DPA-714 monitors antitumor effect of erufosine in a rat 9L intracranial glioma model.
    Awde AR, Boisgard R, Thézé B, Dubois A, Zheng J, Dollé F, Jacobs AH, Tavitian B, Winkeler A.
    J Nucl Med; 2013 Dec; 54(12):2125-31. PubMed ID: 24212976
    [Abstract] [Full Text] [Related]

  • 4. Preclinical imaging evaluation of novel TSPO-PET ligand 2-(5,7-Diethyl-2-(4-(2-[(18)F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([ (18)F]VUIIS1008) in glioma.
    Tang D, Nickels ML, Tantawy MN, Buck JR, Manning HC.
    Mol Imaging Biol; 2014 Dec; 16(6):813-20. PubMed ID: 24845529
    [Abstract] [Full Text] [Related]

  • 5. Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18F]Fluoroethoxy)phenyl)-5-Methylpyrazolo[1,5-a]Pyrimidin-3-yl)-N,N-Diethylacetamide (18F-VUIIS1018A) to Image Glioma.
    Tang D, Li J, Nickels ML, Huang G, Cohen AS, Manning HC.
    Mol Imaging Biol; 2019 Feb; 21(1):113-121. PubMed ID: 29869061
    [Abstract] [Full Text] [Related]

  • 6. The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo.
    Winkeler A, Boisgard R, Awde AR, Dubois A, Thézé B, Zheng J, Ciobanu L, Dollé F, Viel T, Jacobs AH, Tavitian B.
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):811-23. PubMed ID: 22270507
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the PBR/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia.
    Martín A, Boisgard R, Thézé B, Van Camp N, Kuhnast B, Damont A, Kassiou M, Dollé F, Tavitian B.
    J Cereb Blood Flow Metab; 2010 Jan; 30(1):230-41. PubMed ID: 19794397
    [Abstract] [Full Text] [Related]

  • 8. Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [¹⁸F]DPA-714.
    Abourbeh G, Thézé B, Maroy R, Dubois A, Brulon V, Fontyn Y, Dollé F, Tavitian B, Boisgard R.
    J Neurosci; 2012 Apr 25; 32(17):5728-36. PubMed ID: 22539835
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of TSPO PET Ligands [18F]VUIIS1009A and [18F]VUIIS1009B: Tracers for Cancer Imaging.
    Tang D, Li J, Buck JR, Tantawy MN, Xia Y, Harp JM, Nickels ML, Meiler J, Manning HC.
    Mol Imaging Biol; 2017 Aug 25; 19(4):578-588. PubMed ID: 27853987
    [Abstract] [Full Text] [Related]

  • 10. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation.
    Chauveau F, Van Camp N, Dollé F, Kuhnast B, Hinnen F, Damont A, Boutin H, James M, Kassiou M, Tavitian B.
    J Nucl Med; 2009 Mar 25; 50(3):468-76. PubMed ID: 19223401
    [Abstract] [Full Text] [Related]

  • 11. Metabolism and quantification of [(18)F]DPA-714, a new TSPO positron emission tomography radioligand.
    Peyronneau MA, Saba W, Goutal S, Damont A, Dollé F, Kassiou M, Bottlaender M, Valette H.
    Drug Metab Dispos; 2013 Jan 25; 41(1):122-31. PubMed ID: 23065531
    [Abstract] [Full Text] [Related]

  • 12. TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma.
    Pigeon H, Pérès EA, Truillet C, Jego B, Boumezbeur F, Caillé F, Zinnhardt B, Jacobs AH, Le Bihan D, Winkeler A.
    Neuro Oncol; 2019 Jun 10; 21(6):755-764. PubMed ID: 30721979
    [Abstract] [Full Text] [Related]

  • 13. PET imaging of neuroinflammation in a rat traumatic brain injury model with radiolabeled TSPO ligand DPA-714.
    Wang Y, Yue X, Kiesewetter DO, Niu G, Teng G, Chen X.
    Eur J Nucl Med Mol Imaging; 2014 Jul 10; 41(7):1440-9. PubMed ID: 24615467
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of PET Imaging Performance of the TSPO Radioligand [18F]DPA-714 in Mouse and Rat Models of Cancer and Inflammation.
    Zheng J, Winkeler A, Peyronneau MA, Dollé F, Boisgard R.
    Mol Imaging Biol; 2016 Feb 10; 18(1):127-34. PubMed ID: 26194010
    [Abstract] [Full Text] [Related]

  • 15. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET.
    Ory D, Postnov A, Koole M, Celen S, de Laat B, Verbruggen A, Van Laere K, Bormans G, Casteels C.
    Eur J Nucl Med Mol Imaging; 2016 Jan 10; 43(1):163-172. PubMed ID: 26323575
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the novel TSPO radiotracer 2-(7-butyl-2-(4-(2-([18F]fluoroethoxy)phenyl)-5-methylpyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide in a preclinical model of neuroinflammation.
    Tang D, Fujinaga M, Hatori A, Zhang Y, Yamasaki T, Xie L, Mori W, Kumata K, Liu J, Manning HC, Huang G, Zhang MR.
    Eur J Med Chem; 2018 Apr 25; 150():1-8. PubMed ID: 29505933
    [Abstract] [Full Text] [Related]

  • 17. Novel Pyrazolo[1,5-a]pyrimidines as Translocator Protein 18 kDa (TSPO) Ligands: Synthesis, in Vitro Biological Evaluation, [(18)F]-Labeling, and in Vivo Neuroinflammation PET Images.
    Damont A, Médran-Navarrete V, Cacheux F, Kuhnast B, Pottier G, Bernards N, Marguet F, Puech F, Boisgard R, Dollé F.
    J Med Chem; 2015 Sep 24; 58(18):7449-64. PubMed ID: 26280386
    [Abstract] [Full Text] [Related]

  • 18. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization.
    James ML, Fulton RR, Vercoullie J, Henderson DJ, Garreau L, Chalon S, Dolle F, Costa B, Guilloteau D, Kassiou M.
    J Nucl Med; 2008 May 24; 49(5):814-22. PubMed ID: 18413395
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of [18F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy.
    Tuominen S, Keller T, Petruk N, López-Picón F, Eichin D, Löyttyniemi E, Verhassel A, Rajander J, Sandholm J, Tuomela J, Grönroos TJ.
    Eur J Nucl Med Mol Imaging; 2021 May 24; 48(5):1312-1326. PubMed ID: 33340054
    [Abstract] [Full Text] [Related]

  • 20. Interrogating Glioma-Associated Microglia and Macrophage Dynamics Under CSF-1R Therapy with Multitracer In Vivo PET/MRI.
    Foray C, Barca C, Winkeler A, Wagner S, Hermann S, Schäfers M, Grauer OM, Zinnhardt B, Jacobs AH.
    J Nucl Med; 2022 Sep 24; 63(9):1386-1393. PubMed ID: 35115369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.